| Joseph David Murphy, MD | |
|
59 Wapiti Ln, Clancy, MT 59634-9656 | |
| (406) 490-3833 | |
| Not Available |
| Full Name | Joseph David Murphy |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | 59 Wapiti Ln, Clancy, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912070459 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ML20008785 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Peters Hospital | Helena, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Peter's Health | 7911814926 | 161 |
News Archive
New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used antiepileptic drugs.
PENTAX Medical highlighted "Quality in Focus: New Technologies Pushing Boundaries" at UEGW 2016, displaying its very latest endoscopic technology designed to support the clinical pathway through enhanced diagnosis and treatment.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
Today, the U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device that can help facilitate minimally invasive surgery.
In an article on the U.S. Department of Defense webpage, the American Forces Press Service reports on the first U.S. National Strategy for Biosurveillance, issued by the White House "to quickly detect a range of global health and security hazards." According to the article, "the Defense Department has a running start in implementing the new plan, a senior defense official said," and "many of the activities described in the strategy are ongoing at DOD."
› Verified 9 days ago
| Entity Name | St. Peter's Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205025145 PECOS PAC ID: 7911814926 Enrollment ID: O20031204001245 |
News Archive
New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used antiepileptic drugs.
PENTAX Medical highlighted "Quality in Focus: New Technologies Pushing Boundaries" at UEGW 2016, displaying its very latest endoscopic technology designed to support the clinical pathway through enhanced diagnosis and treatment.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
Today, the U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device that can help facilitate minimally invasive surgery.
In an article on the U.S. Department of Defense webpage, the American Forces Press Service reports on the first U.S. National Strategy for Biosurveillance, issued by the White House "to quickly detect a range of global health and security hazards." According to the article, "the Defense Department has a running start in implementing the new plan, a senior defense official said," and "many of the activities described in the strategy are ongoing at DOD."
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph David Murphy, MD 59 Wapiti Ln, Clancy, MT 59634-9656 Ph: () - | Joseph David Murphy, MD 59 Wapiti Ln, Clancy, MT 59634-9656 Ph: (406) 490-3833 |
News Archive
New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used antiepileptic drugs.
PENTAX Medical highlighted "Quality in Focus: New Technologies Pushing Boundaries" at UEGW 2016, displaying its very latest endoscopic technology designed to support the clinical pathway through enhanced diagnosis and treatment.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
Today, the U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device that can help facilitate minimally invasive surgery.
In an article on the U.S. Department of Defense webpage, the American Forces Press Service reports on the first U.S. National Strategy for Biosurveillance, issued by the White House "to quickly detect a range of global health and security hazards." According to the article, "the Defense Department has a running start in implementing the new plan, a senior defense official said," and "many of the activities described in the strategy are ongoing at DOD."
› Verified 9 days ago